BOLETÍN HTA

53 / 56

HIPERTENSION / 2013 / VOL. 18
51
Excreción de antihipertensivos en la leche materna
Droga Razón Leche / Plasma
Atenolol
Clonidina
Labetalol
Nifedipino
Diltiazem
Propanolol
Hidralazina
Hidroclorotiazida
Verapamilo
Metildopa
Nitrendipino
Nimodipino
Captopril
Enalapril
3.0
1.5
0.8 - 1.1
1.0
1.0
0.6
0.5
0.4
0.4
0.4
0.2 - 0.5
0.1
0.1
0.01
Bibliografía
1. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, JM. M. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the
International Society for the Study of Hypertension in Pregnancy (ISSHP). . Hypertens Pregnancy 2001;20:9-14.
2. Encuesta Nacional de Salud ENS Chile 2009-2010. (Accessed at )
3. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 2005;330:565.
4. Lecarpentier E, Tsatsaris V, Goffinet F, Cabrol D, Sibai B, Haddad B. Risk factors of superimposed preeclampsia in women with essential chronic hypertension treated
before pregnancy. PLoS One 2013;8:e62140.
5. Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005;46:1243-9.
6. Redman CW, Sargent IL. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta 2008;29 Suppl A:S73-7.
7. ACOG. ACOG Practice Bulletin No. 125: Chronic hypertension in pregnancy. Obstet Gynecol 2012;119:396-407.
8. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002;100:369-77.
9. Tagle R, Acevedo M, Valdés G. Hipertensión arterial en la mujer adulta. Rev Med Chile 2013;141:237.
10. August P. Management of hypertension in pregnant and postpartum women. http://wwwuptodatecom/contents/management-of-hypertension-in-pregnant-
and-postpartum-women. 4 Agosto 2013.
11. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006;354:2443-51.
12. Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis.
Obstet Gynecol 2010;116:402-14.
13. Thorsteinsdottir B, Kane GC, Hogan MJ, Watson WJ, Grande JP, Garovic VD. Adverse outcomes of renovascular hypertension during pregnancy. Nat Clin Pract
Nephrol 2006;2:651-6.
14. Germain AM, Kottman C, Valdés G. Hiperaldosteronismo primario y embarazo: Lecciones obtenidas de 2 casos clínicos. Rev Med Chil 2002;130:1399-405.
15. Okawa T, Asano K, Hashimoto T, Fujimori K, Yanagida K, Sato A. Diagnosis and management of primary aldosteronism in pregnancy: case report and review of
the literature. Am J Perinatol 2002;19:31-6.
16. Valdés G, Kaufmann P, Corthorn J, Erices R, Brosnihan KB, Joyner-Grantham J. Vasodilator factors in the systemic and local adaptations to pregnancy. Reprod
Biol Endocrinol 2009;7:79.
17. Venning S, Freeman LJ, Stanley K. Two cases of pregnancy with coarctation of the aorta. J R Soc Med 2003;96:234-6.
18. Vriend JW, Drenthen W, Pieper PG, et al. Outcome of pregnancy in patients after repair of aortic coarctation. Eur Heart J 2005;26:2173-8.
19. Kelly D, Amadi A. Serial pressure gradients across a thoracic coarctation of the aorta during pregnancy. Eur J Echocardiogr 2005;6:288-90.
20. Lenders JW. Pheochromocytoma and pregnancy: a deceptive connection. Eur J Endocrinol 2012;166:143-50.
21. Beardmore KS, Morris JM, Gallery ED. Excretion of antihypertensive medication into human breast milk: a systematic review. Hypertens Pregnancy 2002;21:85-95.
22. Smith GC, Pell JP, Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet
2001;357:2002-6.
23. Tranquilli AL, Landia B, Giannubilo SR, Sibai BM. Preeclampsia: No longer solely a pregnancy disease. Pregnancy Hypertension: An International Journal of
Women's Cardiovascular Health 2012;2:350-7.
24. Hermes W, Tamsma JT, Grootendorst DC, et al. Cardiovascular risk estimation in women with a history of hypertensive pregnancy disorders at term: a longitudinal
follow-up study. BMC Pregnancy Childbirth 2013;13:126.